サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1710265

糞便移植療法の世界市場レポート 2025年

Fecal Transplant Therapy Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
糞便移植療法の世界市場レポート 2025年
出版日: 2025年04月03日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

糞便移植療法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.0％で27億1,000万米ドルに成長します。予測期間の成長は、治療への生物製剤の採用の増加、慢性疾患の有病率の上昇、生物農薬の使用の増加、新薬の処方の増加、対象病状を持つ患者の増加に起因すると考えられます。予測期間における主な動向としては、マイクロバイオーム研究への注目の高まり、合成代替品の開発、臨床試験の増加、送達方法の進歩、ドナースクリーニングの成長などが挙げられます。

炎症性腸疾患（IBD）の有病率の上昇が糞便移植療法市場の成長を牽引すると予想されます。IBDとは、クローン病や潰瘍性大腸炎などの消化管の慢性炎症を指します。IBD患者の増加は、高度に加工された食品の消費、抗生物質の不適切または頻繁な使用、衛生状態の改善、小児期の感染因子への曝露の減少などの要因に起因しています。糞便移植療法は、健康な腸内細菌叢を回復させることで、IBD患者の炎症を抑え、症状を緩和し、疾患の管理と進行に影響を与える可能性を目指しています。例えば、カナダを拠点とする非営利団体Crohn's and Colitis Canadaは2023年6月、カナダにおけるIBD患者数が2023年の推定32万2,600人から2035年には47万人に達すると予測していると報告しています。したがって、IBDの有病率の増加が糞便移植療法市場の成長を促進しています。

糞便移植療法市場の主な企業は、患者のコンプライアンスを改善し、アクセス性を拡大するために、錠剤ベースの糞便微生物叢移植（FMT）療法などの革新的な治療の開発に注力しています。錠剤ベースのFMT療法は、ドナーの糞便から生きた細菌を経口カプセルに封入するもので、健康な腸内細菌を補充し、腸の健康を増進することを目的としています。例えば、2023年4月、米国のバイオテクノロジー企業Seres Therapeutics Inc.とスイスのヘルスケア企業Nestle Health Science S.A.は、抗生物質治療後の成人におけるクロストリジウム・ディフィシル感染症（rCDI）の再発予防を目的とした経口カプセル治療薬VOWSTを発売しました。全便を移植する従来のFMTとは異なり、VOWSTは健康なヒトドナーからの生菌胞子を利用し、腸内細菌叢の回復を目標としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界糞便移植療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の糞便移植療法市場：成長率分析
  • 世界の糞便移植療法市場の実績：規模と成長, 2019-2024
  • 世界の糞便移植療法市場の予測：規模と成長, 2024-2029, 2034F
  • 世界糞便移植療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の糞便移植療法市場手順別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 便浣腸
  • 便中細菌療法
  • 便移植
  • ヒトプロバイオティクス注入
  • 糞便輸血
  • 世界の糞便移植療法市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • クロストリジウム・ディフィシル感染症
  • 自閉症
  • 肥満
  • パーキンソン病（PD）
  • 糖尿病
  • その他の病気
  • 世界の糞便移植療法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 専門クリニック
  • その他のエンドユーザー
  • 世界の糞便移植療法市場、便浣腸の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 停留浣腸
  • 洗浄浣腸
  • 保持ベースの糞便移植
  • 在宅管理キット
  • 世界の糞便移植療法市場、便中細菌療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 懸濁液ベースの細菌療法
  • カプセル製剤
  • カスタマイズされた細菌製剤
  • 単一菌株製品と複数菌株製品
  • 世界の糞便移植療法市場、便移植の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 直接便移植手術
  • 便懸濁液移植
  • 便カプセル移植
  • 自動便処理システム
  • 世界の糞便移植療法市場、ヒトプロバイオティクス注入のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 単一菌株プロバイオティクス注入
  • 多菌株プロバイオティクス注入
  • プロバイオティクスとプレバイオティクスのブレンド
  • ヘルスケア従事者向け輸液キット
  • 世界の糞便移植療法市場、糞便輸血の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 静脈内糞便輸血
  • 胃瘻チューブによる輸血
  • プレパッケージ便輸血溶液
  • 調査目的の糞便輸血

第7章 地域別・国別分析

  • 世界の糞便移植療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の糞便移植療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 糞便移植療法市場：競合情勢
  • 糞便移植療法市場：企業プロファイル
    • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • Mount Sinai Health System Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Northwestern Medicine Overview, Products and Services, Strategy and Financial Analysis
    • NYU Langone Health Overview, Products and Services, Strategy and Financial Analysis
    • Michigan Medicine Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • UCLA Health
  • Duke University Health System Inc.
  • Stanford Health Care
  • Ferring Pharmaceuticals
  • Cincinnati Children's Hospital Medical Center
  • Emory Healthcare
  • Cambridge University Hospitals NHS Foundation Trust
  • Hamilton Health Sciences Corporation
  • Brigham and Women's Faulkner Hospital Inc.
  • Rebiotix Inc.
  • Seres Therapeutics Inc.
  • UPMC Hillman Cancer Center
  • OpenBiome
  • Center for Digestive Disease
  • BiomeBank Incorporated

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 糞便移植療法市場2029：新たな機会を提供する国
  • 糞便移植療法市場2029：新たな機会を提供するセグメント
  • 糞便移植療法市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r31844

Fecal transplant therapy, or fecal microbiota transplantation (FMT), is a medical procedure that transfers stool from a healthy donor into a recipient's gastrointestinal (GI) tract. This treatment is primarily used to combat recurrent Clostridium difficile infections and other gut-related disorders by restoring the patient's gut flora with beneficial bacteria to enhance digestion and overall health.

The key methods of fecal transplant therapy include fecal enema, fecal bacteriotherapy, stool transplantation, human probiotic infusion, and fecal transfusion. Fecal enema involves introducing healthy donor stool into a patient's colon through an enema to rebalance gut bacteria. FMT is used to treat conditions such as Clostridium difficile infection, autism, obesity, Parkinson's disease (PD), diabetes mellitus, and others, and is administered in settings such as hospitals, specialty clinics, and other healthcare facilities.

The fecal transplant therapy market research report is one of a series of new reports from The Business Research Company that provides fecal transplant therapy market statistics, including fecal transplant therapy industry global market size, regional shares, competitors with a fecal transplant therapy market share, detailed fecal transplant therapy market segments, market trends and opportunities, and any further data you may need to thrive in the fecal transplant therapy industry. This fecal transplant therapy market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fecal transplant therapy market size has grown strongly in recent years. It will grow from $2.02 $ billion in 2024 to $2.15 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing awareness of fecal transplant procedures, high demand for advanced treatment, growing consciousness worldwide, rise in research and development investment, and the increasing prevalence of inflammatory bowel disease.

The fecal transplant therapy market size is expected to see strong growth in the next few years. It will grow to $2.71 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to the increasing adoption of biologics for the treatment, rising prevalence of chronic illnesses, increase in the use of biopesticides, growing prescriptions for novel drugs, and the increase in patients with target medical conditions. Major trends in the forecast period include increasing focus on microbiome research, development of synthetic alternatives, rise in clinical trials, advancements in delivery methods, and growth in donor screening.

The rising prevalence of inflammatory bowel disease (IBD) is expected to drive growth in the fecal transplant therapy market. IBD refers to chronic inflammation of the gastrointestinal tract, including conditions such as Crohn's disease and ulcerative colitis. The increasing number of IBD cases is attributed to factors such as the consumption of highly processed foods, inappropriate or frequent use of antibiotics, improved hygiene, and reduced exposure to infectious agents during childhood. Fecal transplant therapy aims to restore healthy gut microbiota, thereby reducing inflammation and alleviating symptoms in patients with IBD, potentially impacting disease management and progression. For example, in June 2023, Crohn's and Colitis Canada, a Canada-based non-profit organization, reported that the number of IBD patients in Canada is projected to reach 470,000 by 2035, up from an estimated 322,600 in 2023. Therefore, the increasing prevalence of IBD is fueling the growth of the fecal transplant therapy market.

Key companies in the fecal transplant therapy market are focusing on developing innovative treatments, such as pill-based fecal microbiota transplantation (FMT) therapy, to improve patient compliance and expand accessibility. Pill-based FMT therapy involves encapsulating live bacteria from donor feces into oral capsules, aiming to replenish healthy gut bacteria and enhance intestinal health. For instance, in April 2023, Seres Therapeutics Inc., a US-based biotechnology company, and Nestle Health Science S.A., a Switzerland-based healthcare company, launched VOWST, an oral capsule treatment designed to prevent recurrent clostridioides difficile infection (rCDI) in adults following antibiotic treatment. Unlike traditional FMT, which involves transferring whole stool, VOWST utilizes live bacterial spores from healthy human donors, targeting the restoration of the gut microbiome.

In January 2022, OpenBiome, a US-based nonprofit organization, partnered with the University of Minnesota. This strategic collaboration allows OpenBiome to distribute FMT preparations developed by the University of Minnesota using good manufacturing practices, ensuring continued access to fecal microbiota transplantation for patients suffering from recurrent C. difficile infections. The University of Minnesota, a US-based public research institution, focuses on studying various diseases and treatments, including fecal transplant therapy.

Major companies operating in the fecal transplant therapy market are Mayo Clinic, Mount Sinai Health System Inc., Northwestern Medicine, NYU Langone Health, Michigan Medicine, UCLA Health, Duke University Health System Inc., Stanford Health Care, Ferring Pharmaceuticals, Cincinnati Children's Hospital Medical Center, Emory Healthcare, Cambridge University Hospitals NHS Foundation Trust, Hamilton Health Sciences Corporation, Brigham and Women's Faulkner Hospital Inc., Rebiotix Inc., Seres Therapeutics Inc., UPMC Hillman Cancer Center, OpenBiome, Center for Digestive Disease, BiomeBank Incorporated, The Regents of the University of California

North America was the largest region in the fecal transplant therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fecal transplant therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fecal transplant therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fecal transplant therapy market includes revenues earned by entities through donor screening and selection, stool processing and preparation, and post-procedure monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fecal Transplant Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fecal transplant therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fecal transplant therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fecal transplant therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Procedure: Fecal Enema; Fecal Bacteriotherapy; Stool Transplant; Human Probiotic Infusion; Fecal Transfusion
  • 2) By Disease: Clostridium Difficile Infection; Autism; Obesity; Parkinson's Disease (PD); Diabetes Mellitus; Other Diseases
  • 3) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Fecal Enema: Retention Enema; Cleansing Enema; Retention-Based Fecal Transplants; Home Administration Kits
  • 2) By Fecal Bacteriotherapy: Suspension-Based Bacteriotherapy; Capsule Formulations; Customized Bacterial Preparations; Single Strain vs. Multi-Strain Products
  • 3) By Stool Transplant: Direct Stool Transplant Procedures; Stool Suspension Transplant; Stool Capsule Transplant; Automated Stool Preparation Systems
  • 4) By Human Probiotic Infusion: Single-Strain Probiotic Infusions; Multi-Strain Probiotic Infusions; Probiotic Blends With Prebiotics; Infusion Kits for Healthcare Providers
  • 5) By Fecal Transfusion: Intravenous Fecal Transfusion; Transfusion via Gastrostomy Tube; Pre-Packaged Fecal Transfusion Solutions; Fecal Transfusion For Research Purposes
  • Companies Mentioned: Mayo Clinic; Mount Sinai Health System Inc.; Northwestern Medicine; NYU Langone Health; Michigan Medicine
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fecal Transplant Therapy Market Characteristics

3. Fecal Transplant Therapy Market Trends And Strategies

4. Fecal Transplant Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fecal Transplant Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Fecal Transplant Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Fecal Transplant Therapy Market Growth Rate Analysis
  • 5.4. Global Fecal Transplant Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Fecal Transplant Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Fecal Transplant Therapy Total Addressable Market (TAM)

6. Fecal Transplant Therapy Market Segmentation

  • 6.1. Global Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fecal Enema
  • Fecal Bacteriotherapy
  • Stool Transplant
  • Human Probiotic Infusion
  • Fecal Transfusion
  • 6.2. Global Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clostridium Difficile Infection
  • Autism
  • Obesity
  • Parkinson's Disease (PD)
  • Diabetes Mellitus
  • Other Diseases
  • 6.3. Global Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users
  • 6.4. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Fecal Enema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retention Enema
  • Cleansing Enema
  • Retention-Based Fecal Transplants
  • Home Administration Kits
  • 6.5. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Fecal Bacteriotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Suspension-Based Bacteriotherapy
  • Capsule Formulations
  • Customized Bacterial Preparations
  • Single Strain vs. Multi-Strain Products
  • 6.6. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Stool Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Stool Transplant Procedures
  • Stool Suspension Transplant
  • Stool Capsule Transplant
  • Automated Stool Preparation Systems
  • 6.7. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Human Probiotic Infusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Strain Probiotic Infusions
  • Multi-Strain Probiotic Infusions
  • Probiotic Blends With Prebiotics
  • Infusion Kits for Healthcare Providers
  • 6.8. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Fecal Transfusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous Fecal Transfusion
  • Transfusion via Gastrostomy Tube
  • Pre-Packaged Fecal Transfusion Solutions
  • Fecal Transfusion For Research Purposes

7. Fecal Transplant Therapy Market Regional And Country Analysis

  • 7.1. Global Fecal Transplant Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Fecal Transplant Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fecal Transplant Therapy Market

  • 8.1. Asia-Pacific Fecal Transplant Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fecal Transplant Therapy Market

  • 9.1. China Fecal Transplant Therapy Market Overview
  • 9.2. China Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fecal Transplant Therapy Market

  • 10.1. India Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fecal Transplant Therapy Market

  • 11.1. Japan Fecal Transplant Therapy Market Overview
  • 11.2. Japan Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fecal Transplant Therapy Market

  • 12.1. Australia Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fecal Transplant Therapy Market

  • 13.1. Indonesia Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fecal Transplant Therapy Market

  • 14.1. South Korea Fecal Transplant Therapy Market Overview
  • 14.2. South Korea Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fecal Transplant Therapy Market

  • 15.1. Western Europe Fecal Transplant Therapy Market Overview
  • 15.2. Western Europe Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fecal Transplant Therapy Market

  • 16.1. UK Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fecal Transplant Therapy Market

  • 17.1. Germany Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fecal Transplant Therapy Market

  • 18.1. France Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fecal Transplant Therapy Market

  • 19.1. Italy Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fecal Transplant Therapy Market

  • 20.1. Spain Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fecal Transplant Therapy Market

  • 21.1. Eastern Europe Fecal Transplant Therapy Market Overview
  • 21.2. Eastern Europe Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fecal Transplant Therapy Market

  • 22.1. Russia Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fecal Transplant Therapy Market

  • 23.1. North America Fecal Transplant Therapy Market Overview
  • 23.2. North America Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fecal Transplant Therapy Market

  • 24.1. USA Fecal Transplant Therapy Market Overview
  • 24.2. USA Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fecal Transplant Therapy Market

  • 25.1. Canada Fecal Transplant Therapy Market Overview
  • 25.2. Canada Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fecal Transplant Therapy Market

  • 26.1. South America Fecal Transplant Therapy Market Overview
  • 26.2. South America Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fecal Transplant Therapy Market

  • 27.1. Brazil Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fecal Transplant Therapy Market

  • 28.1. Middle East Fecal Transplant Therapy Market Overview
  • 28.2. Middle East Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fecal Transplant Therapy Market

  • 29.1. Africa Fecal Transplant Therapy Market Overview
  • 29.2. Africa Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fecal Transplant Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Fecal Transplant Therapy Market Competitive Landscape
  • 30.2. Fecal Transplant Therapy Market Company Profiles
    • 30.2.1. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Mount Sinai Health System Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Northwestern Medicine Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. NYU Langone Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Michigan Medicine Overview, Products and Services, Strategy and Financial Analysis

31. Fecal Transplant Therapy Market Other Major And Innovative Companies

  • 31.1. UCLA Health
  • 31.2. Duke University Health System Inc.
  • 31.3. Stanford Health Care
  • 31.4. Ferring Pharmaceuticals
  • 31.5. Cincinnati Children's Hospital Medical Center
  • 31.6. Emory Healthcare
  • 31.7. Cambridge University Hospitals NHS Foundation Trust
  • 31.8. Hamilton Health Sciences Corporation
  • 31.9. Brigham and Women's Faulkner Hospital Inc.
  • 31.10. Rebiotix Inc.
  • 31.11. Seres Therapeutics Inc.
  • 31.12. UPMC Hillman Cancer Center
  • 31.13. OpenBiome
  • 31.14. Center for Digestive Disease
  • 31.15. BiomeBank Incorporated

32. Global Fecal Transplant Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fecal Transplant Therapy Market

34. Recent Developments In The Fecal Transplant Therapy Market

35. Fecal Transplant Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Fecal Transplant Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Fecal Transplant Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Fecal Transplant Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer